Multidisciplinary management of acute glaucoma in an elderly depressive patient: A case report

Geriatric depression is one of the most prevalent psychiatric disorders among older adults. The first-line treatment for geriatric depression typically involves the use of antidepressant medications. However, due to age-related physiological changes and the presence of comorbid physical conditions, older patients are often at increased risk of experiencing adverse effects from these medications. Acute glaucoma is a particularly concerning side effect of antidepressants, especially in elderly patients. This article presents a case study demonstrating how exacerbation of ocular side effects can be prevented and how depressive symptoms can be effectively managed by rationalizing medication in elderly patients with depression. This report provides a real-world example of integrating therapeutic strategies, including medication adjustments, with multidisciplinary collaboration in tackling clinical complexities, such as diverse symptoms and high risk in elderly patients. It serves as a valuable reference for clinicians when making treatment decisions in similar cases.
- Wei H, Lin L, Tao L, et al. Psychiatry. 8th ed. Beijing: People’s Medical Publishing House; 2018.
- Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: Themes for the new century. Psychiatr Serv. 1999;50(9):1158-1166. doi: 10.1176/ps.50.9.1158
- Committee on the Mental Health Workforce for Geriatric Populations, Board on Health Care Services, Institute of Medicine. In: Eden J, Maslow K, Le M, Blazer D, editors. The Mental Health and Substance Use Workforce for Older Adults: In whose Hands? Washington, DC: National Academies Press US; 2012.
- Hegeman JM, Kok RM, Van der Mast RC, Giltay EJ. Phenomenology of depression in older compared with younger adults: Meta-analysis. Br J Psychiatry. 2012;200(4):275-281. doi: 10.1192/bjp.bp.111.095950
- Mallery L, MacLeod T, Allen M, et al. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: Questionable benefit and considerations for frailty. BMC Geriatr. 2019;19(1):306. doi: 10.1186/s12877-019-1327-4
- Defrancesco M, Pechlaner R, Kiechl S, et al. What characterizes depression in old Age? results from the bruneck study. Pharmacopsychiatry. 2018;51(4):153-160. doi: 10.1055/s-0043-119417
- Taylor WD. Should antidepressant medication be used in the elderly? Expert Rev Neurother. 2015;15(9):961-963. doi: 10.1586/14737175.2015.1070671
- Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: A review. CNS Drugs. 2010;24(6):501-526. doi: 10.2165/11533180-000000000-00000
- Maina G, Adami M, Ascione G, et al. Nationwide consensus on the clinical management of treatment-resistant depression in Italy: A Delphi panel. Ann Gen Psychiatry. 2023;22(1):48. doi: 10.1186/s12991-023-00478-7
- Fiorillo A, Demyttenaere K, Martiadis V, Martinotti G. Editorial: Treatment resistant depression (TRD): Epidemiology, clinic, burden and treatment. Front Psychiatry. 2025;16:1588902. doi: 10.3389/fpsyt.2025.1588902.
- Wiciński M, Kaluzny BJ, Liberski S, Marczak D, Seredyka- Burduk M, Pawlak-Osińska K. Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known? Surv Ophthalmol. 2019;64(2):185-194. doi: 10.1016/j.survophthal.2018.09.006
- Costagliola C, Parmeggiani F, Semeraro F, Sebastiani A. Selective serotonin reuptake inhibitors: A review of its effects on intraocular pressure. Curr Neuropharmacol. 2008;6(4):293-310. doi: 10.2174/157015908787386104
- Ezra DG, Storoni M, Whitefield LA. Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment. Eye (Lond). 2006;20(1):128-129. doi: 10.1038/sj.eye.6701815
- Symes RJ, Etminan M, Mikelberg FS. Risk of angle-closure glaucoma with bupropion and topiramate. JAMA Ophthalmol. 2015;133(10):1187-1189. doi: 10.1001/jamaophthalmol.2015.2180
- Jain NS, Ruan CW, Dhanji SR, Symes RJ. Psychotropic drug-induced glaucoma: A practical guide to diagnosis and management. CNS Drugs. 2021;35(3):283-289. doi: 10.1007/s40263-020-00790-w
- Tianmei S, Yiru F, Tao L, et al. Clinical use of mirtazapine in the treatment of depressive disorders. Chin J Ment Health. 2014;28(8):7. doi: 10.3969/j.issn.1000-6729.2014.08.015
- Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: Pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197-245. doi: 10.1124/pr.117.014381
- Fritze J, Schneider B, Weber B. Benzodiazepines and benzodiazepine-like anxiolytics and hypnotics. The implausible contraindication of closed angle glaucoma. Nervenarzt. 2002;73(1):50-53. doi: 10.1007/s115-002-8146-8
- Mantravadi AV, Vadhar N. Glaucoma. Prim Care. 2015;42(3):437-449. doi: 10.1016/j.pop.2015.05.008
- Petsas A, Chapman G, Stewart R. Acute angle closure glaucoma - a potential blind spot in critical care. J Intensive Care Soc. 2017;18(3):244-246. doi: 10.1177/1751143717701946